Farther Finance Advisors’s Vaxcyte PCVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.42K | Buy |
136
+37
| +37% | +$1.2K | ﹤0.01% | 3400 |
|
|
2025
Q1 | $3.19K | Buy |
99
+6
| +6% | +$193 | ﹤0.01% | 3221 |
|
|
2024
Q4 | $7.61K | Buy |
93
+7
| +8% | +$573 | ﹤0.01% | 2483 |
|
|
2024
Q3 | $9.83K | Buy |
86
+9
| +12% | +$1.03K | ﹤0.01% | 2375 |
|
|
2024
Q2 | $5.92K | Buy |
77
+10
| +15% | +$769 | ﹤0.01% | 2323 |
|
|
2024
Q1 | $4.47K | Hold |
67
| – | – | ﹤0.01% | 2122 |
|
|
2023
Q4 | $4.21K | Buy |
67
+60
| +857% | +$3.77K | ﹤0.01% | 2057 |
|
|
2023
Q3 | $357 | Buy |
7
+5
| +250% | +$255 | ﹤0.01% | 2345 |
|
|
2023
Q2 | $100 | Buy |
+2
| New | +$100 | ﹤0.01% | 2426 |
|